KRM Ayurveda IPO
ClosedAlready have an account? Apply now
KRM Ayurveda IPO details
Schedule of KRM Ayurveda
| Issue open date | 21 Jan 2026 |
| Issue close date | 23 Jan 2026 |
| UPI mandate deadline | 23 Jan 2026 (5 PM) |
| Allotment finalization | 27 Jan 2026 |
| Refund initiation | 28 Jan 2026 |
| Share credit | 28 Jan 2026 |
| Listing date | 29 Jan 2026 |
| Mandate end date | 07 Feb 2026 |
| Lock-in end date for anchor investors (50%) | 23 Feb 2026 |
| Lock-in end date for anchor investors (remaining) | 24 Apr 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About KRM Ayurveda
KRM Ayurveda, promoted by Mr Puneet Dhawan and Mrs Tanya Dhawan, operates in the AYUSH healthcare segment, combining classical Ayurvedic knowledge with modern clinical practices. The company runs hospitals and clinics across multiple Indian cities and offers telemedicine services for domestic and international patients. Starting as a kidney care specialist, it has expanded to treat chronic and lifestyle conditions, including liver disorders, diabetes, fatty liver, arthritis, and preventive healthcare.
KRM Ayurveda follows a patient-centric model combining in-person consultations, hospital care, and tele-consultations. Revenue comes from healthcare services, wellness programs, and treatments. Key strengths include specialised Ayurvedic expertise, expanding physical and digital presence, personalised treatment protocols, and a growing holistic healthcare brand.
Financials of KRM Ayurveda
Issue size
| Funds Raised in the IPO | Amount |
| Total issue size | 77.49 |
| Fresh Issue – Proceeds go to the company | 77.49 |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capital Expenditure for Telemedicine Facilities | 13.67 (17.64%) |
| CRM Software & Hardware Infrastructure | 1.42 (1.83%) |
| Human Resources | 5.44 (7.02%) |
| Repayment / Prepayment of Loan | 12.5 (16.13%) |
| Working capital requirements | 18 (23.23%) |
| General corporate purposes | 26.46 (34.15%) |
Strengths
- Integrated Ayurvedic healthcare model combining hospitals, clinics, and telemedicine.
- Strong promoter experience with deep domain knowledge in Ayurveda.
- Specialised expertise in chronic and lifestyle disease management.
- Growing physical presence across multiple Indian states with global tele-reach.
- Increasing brand recognition in the D2C and holistic healthcare segment.
Risks
- High dependence on North India for a significant portion of revenues.
- Operations are asset-light, with most hospitals and clinics on leased premises.
- Business is working-capital intensive with a history of negative cash flows.
- High employee attrition could impact service quality and scalability.
- Dependence on brand reputation in a highly competitive and unregulated AYUSH market.
Allotment Status for KRM Ayurveda
To check your IPO allotment status:
- Visit the Skyline Financial Services IPO Application Status page.
- Select the company name from the dropdown menu.
- Select and enter one of the following: PAN, Application Number, DP/Client ID, or Account Number/IFSC.
- Click Submit to view your allotment status.
Subscription Figures for KRM Ayurveda
As per media reports (Link), the Grey Market Premium (GMP) of KRM Ayurveda is reported at ₹21 over the IPO price. This metric is not reliable, and to track IPO interest, it is better to check subscription numbers published by exchanges, which are considered more reliable indicators.
Subscription numbers as of 05:00 PM on January 23, 2026:
| Category | Reserved (lakhs) | Applied (lakhs) | Subscription (X times) |
|---|---|---|---|
| Institutional | 10.32 | 653.38 | 63.31 |
| NII | 7.80 | 1055.85 | 135.37 |
| Retail | 18.12 | 982.22 | 54.21 |
| Total | 36.24 | 2691.45 | 74.27 |